Causaly
Company

Last deal

$60.M

Amount

Series B

Stage

13.07.2023

Date

5

all rounds

$83.M

Total amount

General

About Company
Causaly's biomedical research tool unlocks hidden evidence in biomedicine.

Industry

Sector :

Subsector :

founded date

01.05.2017

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The platform allows for deep searches and complex research questions to be answered quickly, amplifying human cognitive abilities and accelerating research work. By teaching computers to read all knowledge ever published, Causaly is expanding the boundaries of discovery and providing an interface for humans to answer questions they can't ask anywhere else.
Contacts

location

Phone number

Social url